Kathleen Tregoning, Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, holds 10.67K shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 35.00K shares in Spero Therapeutics (Ticker: SPRO). Most recently, Kathleen Tregoning Bought ― shares of Cerevel Therapeutics Holdings on Dec 28, 2023 for an estimated value of 31.66K.